Title
An approach for interlaboratory comparison of conventional and real-time PCR assays for diagnosis of human leishmaniasis
Date Issued
01 July 2013
Access level
metadata only access
Resource Type
journal article
Publisher(s)
Elsevier
Abstract
Protozoa of the Leishmania genus are transmitted to humans by the bite of infected sandflies, and are the causative agents of leishmaniasis which ranges from cutaneous to visceral clinical forms. The definitive diagnosis of leishmaniasis has relied traditionally on parasite demonstration, either by microscopy or culture; in the last years, diagnosis based on PCR methods has overcome some drawbacks of traditional methods, increasing sensitivity and allowing using less invasive sampling for diagnosis. However, there are not defined protocols and almost each laboratory applies its own in-house method. Although there are several studies comparing the performance of different methods within the same laboratory, those addressing interlaboratory comparison are scarce, in spite of the growing number of collaborative projects between partners from different leishmaniasis endemic and non-endemic countries. In this work we propose a protocol for interlaboratory comparison of conventional and real-time PCR methods involving four participant laboratories from four different endemic regions in four continents; the protocol includes a quality control step and reduces the variability among the samples tested by each participant. A panel of 77 samples from human origin and 9 from different parasite strains was blindly tested by the participants, aiming to assess the sensitivity of the different methods as well as their usefulness for species identification. Real-time PCR methods targeting the kDNA minicircles returned the highest sensitivity, while both PCR targeting ITS-1 and further HaeIII digestion and a combined algorithm including hsp70 PCR and restriction fragment length polymorphism analysis were the most appropriate approaches for species identification. © 2013 Elsevier Inc.
Start page
281
End page
289
Volume
134
Issue
3
Language
English
OCDE Knowledge area
Enfermedades infecciosas
Scopus EID
2-s2.0-84877813052
PubMed ID
Source
Experimental Parasitology
ISSN of the container
1090-2449
Sponsor(s)
The present work was funded by the European Commission FP7 , through the project Pre-clinical studies of a PSA-based human vaccine candidate targeting visceral, cutaneous and mucocutaneous leishmaniasis and development of the associated procedures for further clinical trials-RAPSODI, Grant agreement no: 223341 . The funder had no role in study design, analysis, interpretation of data, writing of the report or the decision to submit the article for publication.
Sources of information: Directorio de Producción Científica Scopus